These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 17905097
1. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Liu HT, Kuo HC. Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097 [Abstract] [Full Text] [Related]
2. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. Liu HT, Tyagi P, Chancellor MB, Kuo HC. BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864 [Abstract] [Full Text] [Related]
3. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. Kuo HC, Chancellor MB. BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543 [Abstract] [Full Text] [Related]
4. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis: a molecular mechanism. Namazi H. Urology; 2008 Aug; 72(2):463-4; author reply 464. PubMed ID: 18407329 [No Abstract] [Full Text] [Related]
5. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M. J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870 [Abstract] [Full Text] [Related]
6. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Urology; 2004 Nov; 64(5):871-5; discussion 875. PubMed ID: 15533466 [Abstract] [Full Text] [Related]
7. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M. Eur Urol; 2006 Apr; 49(4):704-9. PubMed ID: 16417964 [Abstract] [Full Text] [Related]
8. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB. Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859 [Abstract] [Full Text] [Related]
9. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Liu HT, Chancellor MB, Kuo HC. Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208 [Abstract] [Full Text] [Related]
14. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Lee CL, Kuo HC. Pain Physician; 2013 Oct; 16(2):109-16. PubMed ID: 23511677 [Abstract] [Full Text] [Related]